We report a novel cause of Perrault syndrome, which shares the common pathology of disrupted 103 mitochondrial translation. Affected individuals in a large consanguineous family are homozygous for 104 a missense variant in KIAA0391 (MIM 609947), encoding Proteinaceous RNase P (PRORP, also 105 known as mitochondrial RNase P protein 3 (MRPP3)), one of the three subunits of the mitochondrial 106
RNase P (mtRNase P) complex. In humans, mtRNase P comprises TRMT10C-SDR5C1-PRORP (also 107 called MRPP1-MRPP2-MRPP3, respectively), and is responsible for cleaving the 5' end of 108 mitochondrial tRNAs from long polycistronic precursor transcripts (15, 16) . We demonstrate that the 109 KIAA0391 disease-associated variant impairs mtRNase P activity, resulting in the accumulation of 110 unprocessed polycistronic mitochondrial transcripts and leading to a loss of steady-state levels of 111 mitochondrial oxidative phosphorylation (OXPHOS) components. Expression of wild type KIAA0391 112 in patient fibroblasts rescued tRNA processing. Finally, immunohistochemistry analyses of mouse 113 auditory sensory epithelium showed prominent levels of PRORP in the efferent synapses and nerve 114 fibres of the auditory hair cells, highlighting a plausible pathology for the sensorineural hearing loss 115 observed in affected individuals. 116
117

Results
118
Clinical report 119
A consanguineous Palestinian family of three affected female siblings, two unaffected female 120 siblings, two unaffected male siblings and their unaffected parents were ascertained (Fig. 1A) . All 121 three affected sisters showed absent middle ear acoustic reflex, despite normal tympanometry, when 122 tested in infancy and subsequent audiology examinations in each revealed profound bilateral SNHL 123 (>90 decibels hearing level at all frequencies) (Fig. 1B) . The three affected sisters each presented in 124 their late teenage years with primary amenorrhea. Abdominal ultrasound noted the absence of ovaries 125 in all three affected individuals. Hormonal profiles indicated hypergonadotropic hypogonadism (Fig. 126 1C) with otherwise normal endocrine and biochemical tests and a 46, XX karyotype. The sisters were 127 prescribed estrogen to induce puberty and are currently treated with hormone replacement therapy. 128
Each affected sibling has mild intellectual disability, which is not progressive. The sisters were taught 129 in remedial classes but participate in the full activities of daily living, and one sister has paid 130 employment. Echocardiography for each of the affected sisters was normal. All other physical and 131 neurological examinations were normal and the three sisters each have normal height. 132
133
Exome sequencing and variant confirmation 134
Autozygosity mapping, performed on six siblings, as previously described (17) Fig. 1A and 1D ). Sequence analysis of KIAA0391 in five unrelated individuals with Perrault 168 syndrome (11), without a disease-causing variant in the known Perrault syndrome genes, did not 169 identify putative pathogenic variants in a second family. 170
171
Patient cells contain normal levels of mtRNase P but display decreased levels of oxidative 172
phosphorylation (OXPHOS) components containing mitochondria-encoded proteins 173
We investigated the steady-state levels of TRMT10C, SDR5C1 and PRORP in patient fibroblasts by 174
Western blot analysis and found no decrease in the levels of the mtRNase P subunits compared to 175 controls ( Fig. 2A) , suggesting that the p.(Ala485Val) variant does not markedly influence the stability 176 of PRORP or the other mtRNase P subunits. We detected decreased steady-state levels of subunits of 177 respiratory chain complex I (NDUFB8) and complex IV (COXI and COXII) subunits in patient 178 fibroblasts compared to controls -both complexes containing mitochondrial DNA-encoded subunits -179 with no change of other OXPHOS components observed, most notably complex II, which is entirely 180 nuclear-encoded (Fig. 2B) . These results indicate a generalised defect of mitochondrial translation in 181 the patient fibroblasts. 182 From the pre-tRNA transcript containing three tRNAs, the combination of two mtRNase P sites 250 produces five possible fragments (31) (Fig. 5B, 5D and 5E). The variant mtRNase P complex 251 generated markedly less processed tRNA than the wild type complex across all time points and 252 reactions. Quantitative phosphorimaging revealed a diminution of cleavage products by ~35-45% 253 (p<0.01) depending on the pre-tRNA substrate used (Fig. 5F , 5G, 5H, and Supplemental Fig. S3B) . 254
There was no significant difference in the reduction of 5'-end processing by PRORP p.Ala485Val-255 containing mtRNase P between the different pre-tRNA substrates analysed (p>0.05), consistent with 256 the accumulation of both heavy and light-strand transcripts seen in patient fibroblasts (Fig. 3) . 257 
PRORP is present in hair cell synapses and neurons of the mouse organ of Corti 293
To understand why the variant in PRORP, p.Ala485Val, could be associated with hearing loss in the 294 affected family, we undertook localisation studies of PRORP in the mouse organ of Corti. The organs 295 of Corti from C57/BJ6 mice at postnatal (P) day 4 (P4), P16 and P24, were immunofluorescently 296 stained to reveal the localisation of endogenous PRORP. The samples were also counterstained with a 297 presynaptic membrane marker SNAP25 (synaptosome-associated protein 25), and DAPI, a 298 fluorescent stain for double-stranded DNA that highlights the cell nucleus. 299
In mice, the onset of hearing occurs at approximately P12-P14 (32). At P4, the organ of Corti is not 300 fully mature and low levels of SNAP25 protein are detected at presynaptic hair cell membranes 301 The mtRNase P complex is composed of three proteins, TRMT10C-SDR5C1-PRORP, each encoded 363 by the nuclear genome and post-translationally imported into the mitochondria matrix via an N-364 terminal mitochondrial targeting sequence (15, 16). Mitochondrial tRNAs are processed at the 5' end 365 by mtRNase P (15) and at the 3' end by mtRNase Z, encoded by ELAC2 (36, 37). This tRNA 366 processing excises most of the RNA species from the polycistronic mitochondrial precursor 367 transcripts according to the tRNA punctuation model (38, 39) . 368
We observed normal levels of PRORP in patient fibroblasts ( Fig. 2A) , which contrasts with the 369 reduction of the other two subunits of mtRNase P, SDR5C1 (28, 40) and TRMT10C (41) in patients 370 with inherited deficiencies of those proteins. Accumulation of multiple unprocessed transcripts in 371 patient fibroblasts indicated a generalised defect in mitochondrial tRNA processing (Fig. 3) , leading 372 to a mild but observable downstream effect on mitochondrial protein synthesis as evidenced by 373 decreased steady-state levels of complex I and complex IV subunits (Fig. 2B) . A similar, but more 374 pronounced, OXPHOS defect was also observed in patients with pathogenic variants in TRMT10C 375 (41) and HSD17B10 (encoding SDR5C1) (42). OXPHOS deficiency has also been associated with 376
Perrault syndrome in patients with variants in ERAL1 (10). The pattern of OXPHOS deficiency in 377 patients with Perrault syndrome due to ERAL1 variants is similar to that seen in our patient, 378 suggesting that they may share a common pathogenesis. 379
Biallelic variants, which are predicted to result in complete loss of function, have not been identified 380 in any of the three subunits of the mtRNase P complex. All three mtRNase P complex genes are 381 among the core set of genes essential for the survival of cells in tissue culture (43, 44). There are no 382 knockout mouse models for trmt10c and the homozygous knockout of hsd17b10 results in an early 383 embryonic lethal phenotype (45). Knockout of 1110008L16Rik (KIAA0391 homolog) is embryonic 384 lethal, but cardiac and skeletal muscle specific 1110008L16Rik conditional knockout mice have been 385 produced (46). These mice die at 11 weeks due to cardiomyopathy. The conditional knockout mice 386 showed a significant reduction in the synthesis of mitochondrial encoded proteins with no alteration in 387 nuclear encoded proteins. The reduction in mitochondrial-encoded proteins was accompanied by a 388 significant reduction in mitochondrial respiration (46). The mice also showed an accumulation of 389 unprocessed mitochondrial RNA transcripts, but in contrast to patients with defects in subunits of 390 mtRNase P, the mice had no mature transcripts (46). The lack of mature mitochondrial transcripts 391 may be the result of the complete loss of PRORP protein function in mice in comparison to patients 392 with predicted hypomorphic variants in TRMT10C, HSD17B10 or KIAA0391. 393
Despite the similarities in defective mitochondrial tRNA processing, variants in the three subunits of 394 mtRNase P result in markedly differing clinical phenotypes. Pathogenic variants in TRMT10C cause a 395 lethal, childhood multisystem disorder characterised by muscular hypotonia, SNHL and metabolic 396 acidosis (41). Pathogenic variants in HSD17B10, encoding SDR5C1 (protein also known as HSD10, 397 HADH2, MRPP2 or ABAD), cause HSD10 disease, which manifests as a severe, infantile-onset 398 neurodegenerative condition with cardiomyopathy (40, 47). The clinical presentation of Perrault 399 syndrome is less severe than of individuals with TRMT10C (41) and SDR5C1-associated diseases 400 (40). The tissue specific phenotype of Perrault syndrome (SNHL and POI) in comparison to the more 401 systemic presentations of TRMT10C-and SDR5C1-associated phenotypes may be accounted for by 402 the differing function of the proteins. TRMT10C and SDR5C1 are also important for methylation at 403 position 9 of mitochondrial tRNAs, which stabilises the tertiary L-shaped structure of some tRNAs 404 (16),whereas PRORP is required for the nuclease function of mtRNase P only (15, 16). It is possible 405 that more deleterious variants in KIAA0391 would result in further reduction in PRORP activity and a 406 more severe multisystem disorder, similar to that seen in individuals with LARS2 variants (48). 407
Conversely, hypomorphic alleles in KIAA0391 could result in milder degrees of SNHL or POI only. Recently, the expression levels of hearing loss genes were examined in different areas of the mouse 415 cochlea. Four of the six genes associated with Perrault syndrome were examined, and it was found 416 that they showed higher expression levels in the spiral ganglion neurons than in other parts of the 417 cochlea, including the organ of Corti (49 
Materials and Methods
441
Ethical approval 442
All patients provided written informed consent in accordance with local regulations. Ethical approval 443 for this study was granted by the National Health Service Ethics Committee (16/WA/0017) and 444
University of Manchester. The NIH Animal Use Committee approved protocol 1263-15 to T.B.F. for 445
mice. 446
Autozygosity mapping and whole exome sequencing 447
Autozygosity mapping was performed on six members of the family (II-1, II-2, II-3, II-4, II-6 and II-448 7) using the Affymetrix Genome-wide SNP6.0 arrays as previously described (17). Whole exome 449 sequencing was performed on DNA extracted from lymphocytes from individual II-3. The Agilent 450
SureSelect Human All Exon V5 Panel was used for library preparation and sequencing was performed 451 on the HiSeq 2500 (Illumina) as previously described (50). The variant KIAA0391 c.1454C>T; 452 p.(Ala485Val) has been submitted to the relevant LOVD database (http://www.lovd.nl/3.0/home). 453
Confirmation of variants 454
Variants were confirmed in the family via Sanger sequencing using the ABI big Dye v3.1 455 (ThermoFisher) sequencing technology. Primer sequences are available on request. 456
Assessment of protein and RNA levels in patient fibroblasts 457
Western blot analyses for the mtRNase P subunits were performed as previously described (28) using 458 cell lysates from dermal fibroblasts (II-4). 30 mg of protein was separated on a 10% SDS-459 polyacrylamide gel and transferred to a polyvinylidene difluoride membrane (GE Healthcare). 460
Membranes were blocked and subsequently incubated with the primary antibodies (28) and detected 461 with HRP-conjugated secondary antibodies (Dako). The blots were developed using the ECL Western 462
Blotting Analysis Detection system (GE Healthcare). 463
Western blots for the respiratory chain complexes (n=3) were performed using fibroblast cell lysates 464 (II-4). Cell lysates were incubated with sample dissociation buffer, separated by 12% SDS-PAGE and 465 Northern blot analysis was performed as previously described (28). The NorthernMax kit from 471 Ambion was used. 2-5 µg of total RNA, from fibroblasts (II-4), was separated on a 1% denaturing 472 agarose gel. RNA was then transferred to nylon membrane (Hybond-N + Amersham, GE Healthcare) 473 by capillary transfer, UV cross-linked and subjected to hybridization with biotinylated probes. Signals 474 were detected using the BrightStar BioDetect kit (Ambion). A biotinylated RNA size marker 475 (BrightStar RNA Millenium Marker, Ambion) was used to determine the size of RNA species. Probe 476 sequences as previously described (28) . 477
Preparation of the PRORP p.Ala485Val sequence for bacterial expression 478
The plasmid pET28-b(+) containing the coding sequence for PRORP (15) was mutagenized as 479 previously described (51) with the synthetic oligonucleotide PRORP_p.Ala485Val (see Supplemental 480 data for oligonucleotide sequence). The potential mutagenized plasmids were extracted using the 481 GenElute HP Plasmid miniprep Kit (Sigma Aldrich) and the variant was confirmed by DNA 482
sequencing. 483
Recombinant expression and purification of TRMT10C, SDR5C1 and PRORP (wt and 484
p.Ala485Val) 485
The templates for recombinant expression of TRMT10C, SDR5C1 and PRORP were as detailed in 486 (15) and above. Expression was induced in E.coli Rosetta2 DE3 (Novagen) using Overnight Express 487 medium (Novagen). Affinity chromatography of the His-tagged proteins was performed as previously 488 described (15). Their purity was assessed by SDS-PAGE. Aliquots of purified proteins were dialysed 489 overnight at 4°C in 20 mM Tris-Cl pH 7.4, 100 mM NaCl, 15% glycerol, then flash frozen and stored 490 at -80°C. 491
Preparation of mitochondrial pre-tRNA transcripts 492
The templates for pre-tRNA Tyr and pre-tRNA Ile were as described in (15). The template for the pre-493 tRNA His-Ser(AGY)-Leu(CUN) was as described in the Supplemental data. Run off in vitro transcription to 494 produce body labelled pre-tRNA substrate was performed as previously described (52). 495
Pre-tRNA processing assays 496
Pre-tRNA processing assays were performed as previously described (15, 53). The TRMT10C, 497 SDR5C1 and PRORP proteins were mixed in a 2:4:1 molar ratio as described (15). 6% (w/v) 498 acrylamide 8M urea gels were used to resolve substrate and cleavage products. Dried gels were 499 exposed to X-ray film at -80°C or exposed to a phosphorimaging screen to detect assay precursors, 500 intermediates and products. See Supplemental Materials for further details. 501
Real-time PCR 502
Real-time PCR and analysis was performed as previously described (28). Total RNA was isolated 503 from patient and control dermal fibroblasts and treated with DNase. Reverse transcription was 504 performed using tRNA specific primers containing an adaptor sequence for subsequent real-time 505 PCR. Primers sequences are as previously described (28). Real time PCR was performed using 506 standard conditions (60°C elongation, 40 cycles) and relative expression of precursor transcripts in 507 patient fibroblasts was calculated using the ct value for the appropriate transcript from three different 508 healthy controls. Ubiquitin B expression served as the reference for both patient samples and controls. 509
Rescue experiments 510
The coding sequence of wild type KIAA0391 was cloned in an expression vector as described 511 previously (28). The coding sequence was verified by Sanger sequencing. Patient dermal fibroblasts 512 (2.0 x 10 5 ) were seeded in 25 cm 2 flasks and cultivated in 4 ml MEM medium. The next day cells 513 were transfected using 3µg plasmid DNA (PRORP-vector and empty vector as transfection control) 514 and 7.5 µl Turbofect transfection reagent and cultured for additional 48 hours. The cells were then 515 harvested and precursor tRNAs were quantified by real-time PCR as described previously (28) . 516
Localisation of PRORP in the mouse organ of Corti 517
The NIH Animal Use Committee approved protocol 1263-15 to T.B.F. for mice. C57/BJ6 mice at 518 ages P4, P16 and P24 were euthanised, the cochlear capsule was removed and fixed with 4% 519 paraformaldehyde in PBS for 2 hours. The samples were microdissected and the organ of Corti was 520 permeabilised with 1% Triton X-100 in PBS for 30 min followed by three 10 min washes with 1X 521 PBS. Nonspecific binding sites were blocked with 5% normal goat serum and 2% BSA in PBS for 1 h 522 at room temperature. Samples were incubated for 2 h with rabbit polyclonal PRORP antibody 523 (MRPP3, Proteintech -Catalog number: 20959-1-AP) at 1µg/ml and mouse monoclonal SNAP25 524 antibody (Santa Cruz, sc-136267) at 1µg/ml followed by several rinses with PBS. Samples were 525 incubated with goat anti-rabbit IgG Alexa Fluor 488 conjugated secondary antibody and goat anti-526 mouse Alexa Fluor 568 conjugated secondary antibody (Molecular Probes) for 30 min. Samples were 527 washed several times with PBS and were mounted with ProLongGold Antifade staining reagent with 528 DAPI (Molecular Probes) and examined using LSM780 confocal microscope (Zeiss Inc) equipped 529 with 63X, 1.4 N.A. objective. 530
Statistical analysis 531
The Wilcoxon paired test (N=<20) was used with a significance value of 0.05 to test for differences 532 between the wild type and p.Ala485Val pairs for each pre-tRNA substrate. 533
To test for differences in the percentage reduction in the tRNA output of the p.Ala485Val variant 534 between substrates the data was determined to be normally distributed using the Shapiro-Wilk test. 535
One-way ANOVA with a significance value of 0.05 was used to test for differences. 
